22 May 2013
Keywords: argatroban, oked, new, use, usa, glaxosmithkline, texas
Article | 15 April 2002
GlaxoSmithKline and Texas Biotechnology have been awarded marketingapproval in the USA for a new use on their anticoagulant drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 April 2002
© 2013 thepharmaletter.com